Suppr超能文献

脂蛋白相关磷脂酶A2在毕赤酵母中的克隆、表达及纯化

Cloning, expression, and purification of lipoprotein-associated phospholipase A(2) in Pichia pastoris.

作者信息

Zhang Fujun, Wang Yiping

机构信息

State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Shanghai Institutes for Biological Sciences, Graduate School, Chinese Academy of Sciences, Shanghai 201203, China.

出版信息

Mol Biotechnol. 2006 May;33(1):29-36. doi: 10.1385/MB:33:1:29.

Abstract

Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) has been shown to play a crucial role in atherosclerosis, and has been proposed as a promising target for drug discovery. Here, we cloned the Lp-PLA(2) gene from differentiated THP-1 cells, and inserted a carboxy-terminal His(6)-tagged version of the gene into the pPIC9 Pichia expression vector. The Lp-PLA(2) fusion protein was successfully expressed in Pichia pastoris expression system and could be rapidly purified to apparent homogeneity using a single-step purification method. The activity of our recombinant Lp-PLA(2) was strong when [3H] PAF was used as a substrate, and the Lp-PLA(2) inhibitor SB435495 exhibited an inhibitory curve against the recombinant Lp-PLA2 (IC50 = 15.93 +/- 1 microM). This novel recombinant Lp-PLA(2) could prove useful as a screening model for Lp-PLA(2) inhibitors, and may facilitate further investigation of this protein in atherosclerosis.

摘要

脂蛋白相关磷脂酶A2(Lp-PLA2)已被证明在动脉粥样硬化中起关键作用,并已被提议作为药物研发的一个有前景的靶点。在此,我们从分化的THP-1细胞中克隆了Lp-PLA2基因,并将该基因的一个羧基末端带有His(6)标签的版本插入到pPIC9毕赤酵母表达载体中。Lp-PLA2融合蛋白在毕赤酵母表达系统中成功表达,并且可以使用单步纯化方法快速纯化至表观均一性。当以[3H]PAF作为底物时,我们的重组Lp-PLA2活性很强,并且Lp-PLA2抑制剂SB435495对重组Lp-PLA2表现出抑制曲线(IC50 = 15.93 +/- 1 microM)。这种新型重组Lp-PLA2可能作为Lp-PLA2抑制剂的筛选模型有用,并可能促进对该蛋白在动脉粥样硬化中的进一步研究。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验